一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
WhatsApp
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Deucravacitinib Impurity
Deucravacitinib Impurity
  • Deucravacitinib Impurity
  • Deucravacitinib Impurity
  • Deucravacitinib Impurity
  • Deucravacitinib Impurity
  • Deucravacitinib Impurity

Deucravacitinib Impurity NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-12-16

Product Details

Product Name: Deucravacitinib Impurity CAS No.: 1609394-08-2
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/12/16

Deucravacitinib Impurity ; 1609394-08-2

Article illustration


Product Information

  • Product Code:D084002

  • English Name:Deucravacitinib Impurity 2

  • English Alias:3-(2-methoxy-3-nitrophenyl)-1-methyl-1H-1,2,4-triazole

  • CAS No.:1609394-08-2

  • Molecular Formula:C??H??N?O?

  • Molecular Weight:234.21

Advantages

  • High-Purity Reference Standard:Confirmed by HPLC (≥99.0%), NMR (1H, 13C), HRMS, and elemental analysis, suitable for Deucravacitinib impurity analysis and quality control.

  • Stability Assurance:Stable for 36 months at -20℃ under light-protected, sealed storage; degradation rate <0.3% in methanol-water solution within 6 months.

Applications

  • Quality Control Testing:Used for UPLC-MS/MS detection of Impurity 2 in Deucravacitinib API and formulations, controlling content to meet ICH Q3A standards (single impurity limit ≤0.1%).

  • Process Optimization Research:Monitors Impurity 2 formation during Deucravacitinib synthesis, reducing generation by >40% by adjusting nitration temperature (e.g., 0 - 5℃) and reaction time.

  • Method Validation:Serves as a standard for developing impurity detection methods, verifying UPLC resolution (≥3.0) and LOD (0.01 ng/mL).

Background Description

Deucravacitinib, a novel tyrosine kinase 2 (TYK2) inhibitor, is used for treating autoimmune diseases such as psoriasis. Impurity 2, as a process-related impurity of Deucravacitinib, may originate from side products of substitution reactions between triazole rings and nitrobenzene during synthesis. Its nitro and triazole groups may affect drug stability, safety, and efficacy. With stricter requirements from global regulatory agencies for impurities in innovative drugs, studying Impurity 2 is crucial for ensuring Deucravacitinib's quality.

Research Status

  • Detection Technology:UPLC-MS/MS with C18 column (1.7μm) and 0.1% formic acid-acetonitrile gradient elution achieves separation within 5 minutes, with LOD of 0.005 ng/mL for trace impurity analysis.

  • Formation Mechanism:Formed by nucleophilic substitution of 1-methyl-1H-1,2,4-triazole with 2-methoxy-3-nitrochlorobenzene under alkaline conditions (e.g., potassium carbonate/DMF system); optimizing catalyst dosage and reaction solvent polarity inhibits side reactions.

  • Safety Evaluation:In vitro cytotoxicity shows IC?? of 185.6 μM against HaCaT cells (Deucravacitinib IC??=12.3 μM), with lower toxicity than the main drug but requiring strict content control. Long-term stability testing is ongoing to monitor degradation under different humidity, light, and temperature conditions.


WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com


NOTE!

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 



Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
VIP3Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2026-08-02
$54.00
VIP4Y
TargetMol Chemicals Inc.
2026-07-27
$54.00
VIP6Y
TargetMol Chemicals Inc.
2026-07-27
INQUIRY
万全县| 新宁县| 麻阳| 红原县| 新密市| 稻城县| 康平县| 定安县| 济源市| 闻喜县| 左贡县| 五大连池市| 微博| 固阳县| 原平市| 措美县| 赤壁市| 闽清县| 高邮市| 双江| 汶川县| 舞钢市| 大名县| 沾益县| 武陟县| 应用必备| 长宁县| 开鲁县| 华阴市| 舞钢市| 日土县| 桦川县| 珠海市| 彩票| 利津县| 囊谦县| 南华县| 多伦县| 东海县| 黄冈市| 遂平县|